School project · Delayed data · Not financial adviceTerms
SingularityViewAll companies

Stock research

EXAGEN INC. XGN

Healthcare · Diagnostics & Research

$8.42last close 2026-10-09 · market cap $203.98M · delayed data

Trailing returns

1M+15.18%
3M+82.25%
6M+172.49%
1Y-24.01%
5Y-33.54%

Basis: Adjusted daily closes.

What it does

Exagen Inc. designs, develops, and commercializes various testing products under the AVISE brand in the United States. The company enables healthcare providers to care for patients through the diagnosis, prognosis, and monitoring of complex rheumatic, and autoimmune and autoimmune-related diseases, including systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA).

Open XGN in the live terminal →

Valuation, cost of capital, SEC filings, ownership and more, with the source named on every figure.

Post on XLinkedInEmail

Where these figures come from

Delayed data. Not financial advice. Figures are read from the sources above at the dates shown; nothing here is a recommendation. Disclosures · All companies